Downregulation of signal transducer and activator of transcription 3 by sorafenib: a novel mechanism for hepatocellular carcinoma therapy.
about
Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapyEvolving role of Sorafenib in the management of hepatocellular carcinoma.Comparative Metabolomic Profiling of Hepatocellular Carcinoma Cells Treated with Sorafenib Monotherapy vs. Sorafenib-Everolimus Combination Therapy.Very-long-chain fatty acid sphingomyelin in nuclear lipid microdomains of hepatocytes and hepatoma cells: can the exchange from C24:0 to C16:0 affect signal proteins and vitamin D receptor?Anticancer effect of cucurbitacin B on MKN-45 cells via inhibition of the JAK2/STAT3 signaling pathway.Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor REffect of Pomegranate Hull Extract on Liver Neoplastic Changes in Rats: More than an Antioxidant.Sorafenib effect on liver neoplastic changes in rats: more than a kinase inhibitor.Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib.Chemical and genetic inhibition of STAT3 sensitizes hepatocellular carcinoma cells to sorafenib induced cell death.The Roles of Protein Tyrosine Phosphatases in Hepatocellular Carcinoma.
P2860
Q28080262-0ACBA6D0-E129-4DD6-8C82-C661B9DF8D2DQ33779864-61DAD8EF-8685-4E3D-84EE-0453CB85EC97Q35776357-3D1788FB-BCCD-4435-BAF2-6ED63E4B49EDQ36063642-70054692-CD91-42A7-8F6F-4EA977479CC6Q39326252-13A45303-C31F-460F-9497-6CBAEABC1125Q47107119-F3EA4C2B-DB28-43E7-A591-2A90BBA36383Q51660023-613AED5E-93BA-420D-9DBA-B167E6F3155CQ52874658-92CECFB5-D192-4FF6-B67E-C1D618B00FEBQ54291692-9C4736E0-46A7-4C4E-9932-6C63C5394C70Q55180385-8CBC2CBE-FBE4-42BE-A307-AE2603AEBACCQ55260605-AADB0AB2-4D91-42A5-9743-60A1FCA2F116
P2860
Downregulation of signal transducer and activator of transcription 3 by sorafenib: a novel mechanism for hepatocellular carcinoma therapy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Downregulation of signal trans ...... atocellular carcinoma therapy.
@ast
Downregulation of signal trans ...... atocellular carcinoma therapy.
@en
Downregulation of signal trans ...... atocellular carcinoma therapy.
@nl
type
label
Downregulation of signal trans ...... atocellular carcinoma therapy.
@ast
Downregulation of signal trans ...... atocellular carcinoma therapy.
@en
Downregulation of signal trans ...... atocellular carcinoma therapy.
@nl
prefLabel
Downregulation of signal trans ...... atocellular carcinoma therapy.
@ast
Downregulation of signal trans ...... atocellular carcinoma therapy.
@en
Downregulation of signal trans ...... atocellular carcinoma therapy.
@nl
P2093
P2860
P1476
Downregulation of signal trans ...... patocellular carcinoma therapy
@en
P2093
Chung-Wai Shiau
Man-Hsin Hung
Wei-Tien Tai
P2860
P304
15269-15274
P356
10.3748/WJG.V20.I41.15269
P407
P577
2014-11-01T00:00:00Z